← Back to Clinical Trials
Recruiting NCT06727500

Effects of HIIT and Concurrent HITT/Plyometric Training on Muscle-tendon Structure, Function and Metabolism in Pediatric Population With Obesity at Different Biological Maturation States (HIIT-PRO Kids).

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pediatric Obesity
Sponsor Universidad Nacional Andres Bello
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 7 Years
Max Age 17 Years
Start Date 2025-04-01
Completion 2025-08-01
Interventions
HIIT plus plyometric trainingHIIT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The randomized controlled trial will compare the effects of a High-intensity interval training (HIIT) protocol versus a HIIT plus plyometric training in the muscle-tendon structure function and metabolism of the pediatric population with obesity at different biological maturational stages (pre-to-age peak velocity \[APHV\] and post-APHV). Both groups perform baseline evaluations of the main and secondary outcomes and receive the intervention for twelve weeks, three times per week. Once the interventions are completed, the participants undergo the same evaluations they performed at baseline.

Eligibility Criteria

Inclusion Criteria: * Pediatric population with obesity determined by the body mass index by z-score (BMI-z) ≥ 2 standard deviations (SD) and ≤ 3.5 SD of the median for age and sex. * Pediatric population with -1 to -3 APHV (pre-APHV) and +1 to +3 APHV (post-APHV). Exclusion Criteria: * Cognitive Disabilities. * Musculoskeletal condition that prevents regular physical activity. * Severe heart diseases that contraindicate the practice of physical activity. * Individuals who perform supervised exercise in the past six months.

Related Trials

}
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology